Primary Record
Ibrexafungerp
- In stock
- 5,752 g
- Purity
- 98.1 %
- CAS
- 1207753-03-4
Compound Identifiers & Properties
- CAS
- 1207753-03-4
- PubChem CID
- 46871657
- SMILES
- C[C@H](C(C)C)[C@]1(CC[C@@]2([C@H]3CC[C@H]4[C@]5(COC[C@]4(C3=CC[C@]2([C@@H]1C(=O)O)C)C[C@H]([C@@H]5OC[C@@](C)(C(C)(C)C)N)N6C(=NC=N6)C7=CC=NC=C7)C)C)C
- Canonical SMILES
- CC(C)[C@@H](C)[C@@]1(C)CC[C@]2(C)[C@H]3CC[C@@H]4[C@@]5(COC[C@@]4(C)[C@@H](OC[C@](C)(N)C(C)(C)C)[C@H](n4ncnc4-c4ccncc4)C5)C3=CC[C@@]2(C)[C@@H]1C(=O)O
Names & Synonyms
- Ibrexafungerp
- brexafemme
- ibrexafungerpum
- Enfumafungin
- SCY-078
- Ibrexafungerp [USAN]
- MK-3118
- Ibrexafungerp citrate
- A92JFM5XNU
- Ibrexafungerp (USAN)
- RefChem:56932
- MK-3118 FREE BASE
- UNII-A92JFM5XNU
- 1207753-03-4
- D0GW6Q
- IBREXAFUNGERP [INN]
- IBREXAFUNGERP [WHO-DD]
- MK3118
- DTXSID901336871
- orb1699944
- SCHEMBL3479266
- SCY078
- CHEMBL4297513
- MK 3118
- SCY 078
- BODYFEUFKHPRCK-ZCZMVWJSSA-N
- DTXCID401767166
- GLXC-15579
- GLXC-23265
- EX-A7291
- WHO 10597
- XH1529
- AKOS032946516
- DB12471
- Enfumafungin (antifungal), Merck & Co
- HY-107126
- CS-0027375
- NS00072897
- D11544
- A947363
- Q27273787
- Triterpene glycoside analogs (antifungal), Merck & Co
- Enfumafungin analogs (antifungal), Merck & Co/SCYNEXIS
- (1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid
- Antifungal compounds (1,3 beta glucan synthase inhibitors), Merck/SCYNEXIS
- (1R,5S,6R,7R,10R,11R,14R,15S,16R,17R)-16-{[(2R)-2-amino-2,3,3-trimethylbutyl]oxy}-5,7,10,15-tetramethyl-7-[(2R)-3-methylbut-2-yl]-17-[5-(pyridin-4-yl)-1,2,4-triazol-1-yl]-20-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2(3)-ene-6-carboxylic acid
- (1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-((2R)-2-amino-2,3,3-trimethylbutoxy)-5,7,10,15-tetramethyl-7-((2R)-3-methylbutan-2-yl)-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo(13.3.3.01,14.02,11.05,10)henicos-2-ene-6-carboxylic acid
- (1S,4AR,6AS,7R,8R,10AR,10BR,12AR,14R,15R)-15-((2R)- 2-AMINO-2,3,3-TRIMETHYLBUTOXY)-1,6A,8,10A-TETRAMETHYL-8- ((2R)-3-METHYLBUTAN-2-YL)-14-(5-(PYRIDIN-4-YL)-1H-1,2,4- TRIAZOL-1-YL)-1,6,6A,7,8,9,10,10A,10B,11,12,12A-DODECAHYDRO-2H,4H-1,4A-PROPANOPHENANTHRO(1,2-C)PYRAN-7-CARBOXYLIC ACID
- (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)-15-[(2R)-2-Amino-2,3,3-trimethylbutoxy]-8-[(1R)-1,2-dimethylpropyl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-14-[5-(4-pyridinyl)-1H-1,2,4-triazol-1-yl]-4H-1,4a-propano-2H-phenanthro[1,2-c]pyran-7-carboxylic acid
- (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)-15-[[(2R)-2-amino-2,3,3-trimethylbutyl]oxy]-8-[(1R)-1,2-dimethylpropyl]-14-[5-(4-pyridinyl)-1H-1,2,4-triazol-1-yl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-4H-1,4a-propano-2H-phenanthro[1,2-c]pyran-7-carboxylic acid
- 4H-1,4A-PROPANO-2H-PHENANTHRO(1,2-C)PYRAN-7-CARBOXYLIC ACID, 15-((2R)-2-AMINO-2,3,3-TRIMETHYLBUTOXY)-8-((1R)-1,2-DIMETHYLPROPYL)-1,6,6A,7,8,9,10,10A,10B,11,12,12A-DODECAHYDRO-1,6A,8,10A-TETRAMETHYL-14-(5-(4-PYRIDINYL)-1H-1,2,4-TRIAZOL-1-YL)-, (1S,4AR,6AS,7R,8R,10AR,10BR,12AR,14R,15R)-